Long-Term Outcomes after Double Free Flap Reconstruction for Locally Advanced Head and Neck Cancer

2018 ◽  
Vol 35 (01) ◽  
pp. 066-073 ◽  
Author(s):  
J. Brinkman ◽  
Shoista Kambiz ◽  
Tim de Jong ◽  
Marc Mureau

Background The use of simultaneous, multiple free flaps has become a reliable reconstructive option in patients with extensive composite defects after resection of locally advanced head and neck cancer. However, some reluctance remains among reconstructive surgeons with concerns regarding flap outcomes and limited patient survival. Therefore, we evaluated complications, long-term patient survival, and patient-reported outcomes following these extensive head and neck reconstructions. Methods All consecutive patients treated with multiple free flaps for reconstruction of extensive composite defects after resection of locally advanced head and neck cancer between 1999 and 2014 were retrospectively reviewed. Patient charts were evaluated for demographics, treatment details, complications, and patient survival. In addition, all patients alive at the start of the study were asked to complete the 10-item Eat Assessment Tool (EAT-10) and the Intelligibility Rating Scale (IRS). Results Eighty-four simultaneous, multiple free flaps were performed in 42 patients. The predominant free flap combination consisted of a fibula with either an anterolateral thigh (n = 22) or a radial forearm flap (n = 14). Complete flap survival was 95%. Nineteen patients were still alive with a mean follow-up of 55 months. Five-year patient survival was 46.3%. Mean EAT-10 score was 8.4 (range: 0–29), with only one patient reporting problematic swallowing. Ninety percent of the patients had moderate to good speech intelligibility with the IRS. Conclusion Multiple, simultaneous free flaps can be performed safely, leading to acceptable long-term patient survival and patient-reported functional outcomes. Our study demonstrates that it is worthwhile to perform these challenging microvascular reconstructions in patients with locally advanced head and neck cancer.

Cancers ◽  
2019 ◽  
Vol 11 (4) ◽  
pp. 551 ◽  
Author(s):  
Chantal M. Driessen ◽  
Janneke C. Ham ◽  
Maroeska te Loo ◽  
Esther van Meerten ◽  
Maurits van Lamoen ◽  
...  

Ototoxicity and nephrotoxicity are potentially irreversible side effects of chemoradiotherapy with cisplatin in locally advanced head and neck cancer (LAHNC) patients. Several predictive genetic variants have been described, but as yet none in LAHNC patients. The aim of this study is to investigate genetic variants as predictors for ototoxicity and nephrotoxicity in LAHNC patients treated with cisplatin-containing chemoradiotherapy. Our prospective cohort of 92 patients was genotyped for 10 genetic variants and evaluated for their association with cisplatin-induced ototoxicity (ACYP2, COMT, TPMT and WFS1) and nephrotoxicity (OCT2, MATE and XPD). Ototoxicity was determined by patient-reported complaints as well as tone audiometrical assessments. Nephrotoxicity was defined as a decrease of ≥25% in creatinine clearance during treatment compared to baseline. A significant association was observed between carriership of the A allele for rs1872328 in the ACYP2 gene and cisplatin-induced clinically determined ototoxicity (p = 0.019), and not for ototoxicity measured by tone audiometrical assessments (p = 0.449). Carriership of a T allele for rs316019 in the OCT2 gene was significantly associated with nephrotoxicity at any time during chemoradiotherapy (p = 0.022), but not with nephrotoxicity at the end of the chemoradiotherapy. In conclusion, we showed prospectively that in LAHNC patients genetic variants in ACYP2 are significantly associated with clinically determined ototoxicity. Validation studies are necessary to prove the added value for individualized treatments plans in these patients.


Author(s):  
Jimmy J. Caudell ◽  
Philip E. Schaner ◽  
Ruby F. Meredith ◽  
Julie L. Locher ◽  
Lisle M. Nabell ◽  
...  

1997 ◽  
Vol 33 (7) ◽  
pp. 1152-1155 ◽  
Author(s):  
S. Dinges ◽  
V. Budach ◽  
M. Stuschke ◽  
W. Budach ◽  
D. Boehmer ◽  
...  

2009 ◽  
Vol 74 (4) ◽  
pp. 1040-1046 ◽  
Author(s):  
Deborah Citrin ◽  
John Mansueti ◽  
Anna Likhacheva ◽  
Linda Sciuto ◽  
Paul S. Albert ◽  
...  

2019 ◽  
Vol 11 (2) ◽  
pp. 192-195
Author(s):  
Khyati Jani ◽  
Nirav Maharaja ◽  
Nisha Rajrattansingh Akali ◽  
Deepak Balasubramanian ◽  
Janarthanan Ramu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document